InvestorsHub Logo

jaybe

10/03/17 7:00 PM

#7 RE: dorothy52 #6

That’s $2B in bio-bucks right? This will be spent over several years on expanded R&D and SGA for US commercial effort. I don’t assume much of these milestones will flow through to earnings for PE. Are you thinking about M&A value? I saw something on IPO about no sale for 3 years...unless of course the offer is exceptional.